Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of polymer/extracellular matrix micro-nano fiber composite material and product thereof

A technology of fiber composite materials and external matrix, applied in medical science, prostheses, absorbent pads, etc., can solve problems affecting tissue remodeling and repair, poor processability, insufficient mechanical strength, etc., to promote in situ tissue regeneration, improve Biological activity, effect of improving cell migration

Active Publication Date: 2022-07-26
纽生(天津)生物科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, simple extracellular matrix materials have poor processability and insufficient mechanical strength after decellularization, making it difficult to apply to tissues with high mechanical requirements (such as blood vessels, abdominal hernia patches, etc.)
In addition, the controllability of the shape and structure of the acellular matrix material is poor, and it is difficult to achieve a good fit with damaged tissues and organs. Moreover, the pore size of the extracellular matrix material is too small, which limits the migration of cells into the scaffold, thereby affecting tissue remodeling and repair.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of polymer/extracellular matrix micro-nano fiber composite material and product thereof
  • Preparation method of polymer/extracellular matrix micro-nano fiber composite material and product thereof
  • Preparation method of polymer/extracellular matrix micro-nano fiber composite material and product thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1 Preparation of polycaprolactone (PCL)-placental extracellular matrix micro-nanofibrous tubular composite material

[0043] Obtain human placental extracellular matrix ( figure 1 ): Decellularization of human placental tissue by a combination of physical, chemical and biological methods. The specific method includes cutting the fresh (or frozen and thawed) human placental tissue into tissue blocks of 1×1 cm, and washing the residual blood in the tissue with normal saline. Afterwards, the tissue block was placed in a container containing 1% (m / v) sterile SDS (sodium dodecyl sulfonate) solution, treated at 4 °C with a shaker at 200 rpm for 24 h, the medium was changed every 6 h, and discarded. SDS solution, and use sterile normal saline to wash away the residual SDS. The tissue samples were treated with a mixture of sterile DNase (50 U / mL) and RNase enzyme (1 U / mL), shaken (100 rpm) for 12 h at room temperature, and washed with sterile saline until no enzyme so...

Embodiment 2

[0056] Example 2 Preparation of Polylactic Acid-Glycolic Acid Copolymer (PLGA)-Liver Extracellular Matrix Micro / Nano Fiber Membrane Composite

[0057] Obtaining porcine liver extracellular matrix: Decellularization of porcine liver tissue using a combination of physical, chemical and biological methods. The specific method includes cutting the purchased fresh porcine liver tissue into 1 mm thick slices, and washing the residual blood in the tissue with normal saline. Afterwards, the tissue was immersed in 0.1% peracetic acid solution, disinfected for 2 h, and then the residual peracetic acid solution was cleaned with sterile water. After that, put an appropriate amount of tissue pieces into a container containing 0.5% (m / v) sterile SDS solution, and treat at 4°C with a shaker at 200 rpm for 24 hours, change the medium every 6 hours, discard the SDS solution, and use sterile normal saline. Wash off the residual SDS. The tissue samples were treated with a mixture of sterile DN...

Embodiment 3

[0060] Example 3 Preparation of polyglycerol sebacate (PGS) / L-polylactic acid (PLLA)-small intestinal submucosa extracellular matrix micro-nanofiber membrane composite material

[0061] Obtaining extracellular matrix of porcine small intestinal submucosa: Decellularization of porcine small intestinal submucosa is carried out by combining physical, chemical and biological methods. The specific method includes: after rinsing the purchased small intestine of pigs, peeling and scraping the submucosa of the small intestine, cutting it into 10 cm long segments, and shaking and washing with sterile water on a shaker. Afterwards, an appropriate amount of tissue was soaked in a 0.1% peracetic acid solution, disinfected for 2 hours, and the residual peracetic acid solution was cleaned with sterile water. Then, sterile 0.25% (w / v) SDS was added, treated at 4°C with a shaker at 200 rpm for 24 hours, the medium was changed every 6 hours, the SDS solution was discarded, and the residual SDS...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation method of a polymer / extracellular matrix micro-nano fiber composite material and a product thereof, and relates to the technical field of tissue engineering. The preparation method comprises the following steps that (1) a spinning solution A and a spinning solution B are prepared, the spinning solution A takes a degradable polymer as a solute, and the spinning solution B takes a decellularized extracellular matrix as a solute; and (2) oppositely spinning the spinning solution A and the spinning solution B onto the same receiver by utilizing electrostatic spinning to obtain the polymer / extracellular matrix micro-nano fiber composite material, the spinning solution A is used for spinning micron fibers, and the spinning solution B is used for spinning nano fibers. The polymer / extracellular matrix micro-nano fiber composite material is prepared by utilizing an electrostatic spinning technology, realizes advantage complementation of a polymer material and an extracellular matrix material, and has mechanical strength and biological activity.

Description

technical field [0001] The invention relates to the technical field of tissue engineering, in particular to a preparation method of a polymer / extracellular matrix micro-nano fiber composite material and a product thereof. Background technique [0002] Tissue defects or deformities will adversely affect the patient's life and affect the patient's physical and mental health. The development of tissue engineering has opened up a new way for the repair of human tissues and organs. The use of biomaterials implanted into damaged parts of tissue for repair has been used in clinical practice and has achieved positive results. The strategy of in situ regeneration is mainly to use biodegradable biomaterials composite activity modification to regulate the local microenvironment to recruit endogenous cells to achieve tissue in situ regeneration, which is a new trend in regenerative medicine. [0003] Biomaterials include synthetic and naturally derived polymeric materials, including de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L27/36A61L27/18A61L27/20A61L27/50A61L27/54A61L15/40A61L15/26A61L15/28A61L15/42A61L15/44
CPCA61L27/3633A61L27/3687A61L27/3691A61L27/18A61L27/20A61L27/50A61L27/54A61L27/507A61L15/40A61L15/26A61L15/28A61L15/42A61L15/44A61L2430/40A61L2400/12A61L2300/412A61L2430/16A61L2430/32C08L67/04C08L5/10
Inventor 朱美峰刘思洋董显豪宋广州
Owner 纽生(天津)生物科技有限公司